Fluvoxamine for Adults With Mild to Moderate COVID-19

NCT04711863 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

400

Enrollment

OTHER

Sponsor class

Stopped Closure of main community treatment center

Conditions

Severe Acute Respiratory Syndrome Coronavirus 2
Coronavirus Infection
Mild to Moderate COVID-19

Interventions

DRUG: Fluvoxamine
DRUG: Placebo

Sponsor

Asan Medical Center